General Technology Group Dalian Machine Tool Co., Ltd. (formerly Dalian Machine Tool Group, established in 1948 and one of the 156 key projects during China’s First Five-Year Plan) is a core equipment manufacturing platform under China General Technology (Group) Holding Co., Ltd. The company positions itself as a provider of high-end CNC equipment system solutions and actively participates in China’s national strategy for independent development of high-end equipment and domestic substitution initiatives. Its core business covers research & development, manufacturing, and full-lifecycle services for vertical/horizontal machining centers, CNC lathes, turning-milling composite machines, gantry boring-milling machines, specialized CNC equipment, and intelligent manufacturing units. Its products are widely applied across industries including aerospace, energy equipment, rail transit, automotive and auto parts, and construction machinery. Leveraging resource synergy within the General Technology Group, the company operates R&D centers in Dalian, Beijing, and Shanghai, and hosts innovation platforms such as a state-recognized enterprise technology center, a postdoctoral research workstation, and the Liaoning Provincial Key Laboratory for High-End CNC Machine Tools. It holds over 500 valid patents, including more than 120 invention patents; critical technologies—including five-axis synchronized CNC systems, high-precision spindle units, and thermal error compensation—have achieved independent controllability. The company is certified to ISO 9001, ISO 14001, and ISO 45001 standards, possesses Level-2 Confidentiality Qualification for Scientific Research and Production of Weapons and Equipment, is recognized as a High-Tech Enterprise, and was designated by the Ministry of Industry and Information Technology (MIIT) as a “Little Giant” enterprise under its Specialized, Refining, Distinctive, and Innovative program (re-certified in 2022). Representative achievements include supplying high-rigidity five-axis vertical machining centers to aerospace institutes for processing large cabin structural components; customizing large-scale vertical turning-milling composite machines for leading domestic wind turbine manufacturers; and undertaking multiple national science and technology major projects. Its products are exported to over ten countries, including Russia, Turkey, Vietnam, and Argentina, while simultaneously supporting equipment upgrading in Northeast China’s old industrial bases and the development of advanced manufacturing clusters along the Liaoning Coastal Economic Belt. Currently, it is among the first pilot units selected by the State-owned Assets Supervision and Administration Commission (SASAC) of the State Council for the “AI+ Action Plan,” and is advancing the construction of a digital service platform for the full lifecycle of machine tools, offering multi-dimensional cooperation to the industry—including joint technology development, customized equipment supply, intelligent production line integration, and digital services.

Contemporary Amperex Technology Co., Limited (CATL) (Stock Code: 300750.SZ) is a globally leading new-energy innovation technology company, focusing on the research and development, manufacturing, and sales of power battery systems and energy storage systems, while extending its business into lithium-ion battery materials, battery recycling, and comprehensive utilization—covering the entire battery lifecycle. Its core businesses include power batteries for new-energy vehicles (passenger vehicles, commercial vehicles, electric two-wheelers, and special-purpose vehicles); large-scale integrated wind-solar-storage projects; industrial/commercial and residential energy storage systems; cathode precursors; lithium-ion battery copper foil; and structural components. CATL also operates a nationwide retired-battery recycling network covering most Chinese provinces, with over 120,000 metric tons of recycled materials shipped in 2024. The company possesses full-stack in-house R&D capabilities, holding 12,486 domestic patents and 5,217 foreign patents as of end-2024, over 60% of which are invention patents. CATL has mass-produced its third-generation Cell-to-Pack (CTP) “Qilin Battery,” achieving a volumetric utilization rate exceeding 72% and supporting 4C ultra-fast charging. Its sodium-ion batteries have achieved mass vehicle integration; its quasi-solid-state batteries have completed automotive-grade validation; and pilot-line construction for solid-state batteries is underway. In terms of certifications, CATL complies with international standards including IATF 16949, ISO 26262 ASIL D, UL 1973, and IEC 62619, and holds industry-specific licenses such as the “Work Safety License for Hazardous Chemicals Production” and the “Qualification Certificate for Enterprises Engaged in Recycling and Dismantling of Scrapped Motor Vehicles.” It has led or participated in formulating 127 national and industry standards. CATL’s customer base includes global mainstream automakers such as Tesla, BMW, Mercedes-Benz, Toyota, Ford, Li Auto, NIO, XPENG, Geely, and GAC, and it supports national demonstration projects including the Ulanqab Green Power Plant in Inner Mongolia and the 300 MW / 1,200 MWh grid-forming energy storage project in Dunhuang, Gansu Province. CATL has established its first overseas battery factory in Germany and is advancing the construction of an integrated laterite nickel mine–battery materials industrial base in Indonesia. Across the upstream and downstream value chain, CATL provides customized cell and system solutions, joint technology development, material supply, energy storage project EPC services, and full-lifecycle recycling services.

Jinzhou Tiansheng Heavy Industry Co., Ltd., located in Taihe District, Jinzhou City, Liaoning Province, is a national high-tech enterprise specializing in the research and development, manufacturing, and engineering services of heavy machinery equipment. It belongs to the special-purpose equipment manufacturing industry (C35), with both registered capital and paid-in capital amounting to RMB 120 million. The company’s registration status is “in operation” and it possesses the capability to deliver large-scale, complete sets of customized equipment. Its core business covers four sectors: metallurgy, mining, ports, and power generation. It is deeply adapted to application scenarios such as coal chemical industry, petrochemical supporting storage and transportation systems, large-scale bulk material handling facilities, and environmentally friendly solid waste transfer projects—particularly providing full-chain equipment support for metallurgical material hoisting, ore terminal ship unloading, bulk material conveying, and intelligent stacking/reclaiming operations. Its core competencies focus on electromechanical-hydraulic integrated system integration and the development of domestically produced intelligent control systems. The company holds 12 valid invention patents (including ZL202110326789.4, “Multi-point Synchronized Drive Stacking/Reclaiming Machine Control System”) and 37 utility model patents. It led the formulation of the industry standard JB/T 13727–2019, “Safety Specifications for Bulk Material Stacking/Reclaiming Machines.” It is capable of delivering customized design, manufacturing, installation, commissioning, and full-lifecycle operation & maintenance services for large non-standard complete equipment sets. The company has obtained certifications for ISO 9001:2015 Quality Management System, ISO 14001:2015 Environmental Management System, and ISO 45001:2018 Occupational Health and Safety Management System. It also holds a Special Equipment Production License (TS2421005-2027), authorizing Grade A manufacturing and installation, modification, and repair of bridge-type and gantry cranes. Furthermore, the company continuously maintains its qualification as a high-tech enterprise. Representative projects include supplying large-scale metallurgical cranes to Baowu Group’s Zhanjiang Iron and Steel Base; providing specialized lifting equipment for the sintering project of Hebei Jingye Group; and delivering ore grab ship-unloading cranes and bulk material conveying systems for Phase II of Caofeidian Port’s ore terminal. Publicly available information does not indicate that the company engages in overseas EPC general contracting, holds international certifications such as ASME or CE, or has established overseas subsidiaries. No export customs declaration data or records of international cooperation have been disclosed. Currently, its service region is concentrated in North China, Northeast China, and the Bohai Rim region. Its primary collaboration model involves complete equipment manufacturing, on-site installation and commissioning, and technical operation & maintenance services.

Shanghai Secco Petrochemical Co., Ltd. is a national-level large-scale Sino-foreign joint venture petrochemical enterprise, jointly established by Sinopec Corporation, China Petroleum & Chemical Corporation (Sinopec Group), and BP PLC of the United Kingdom. The company builds a complete industrial chain centered on ethylene, covering olefins, aromatics, and downstream synthetic resins. Its core business focuses on the research, development, production, and sale of ethylene and its derivatives. Key products include styrene, polypropylene, high-density polyethylene (HDPE) and low-density polyethylene (LDPE), butadiene, and aromatics, which are widely applied in packaging, automotive, construction, medical, and daily chemical industries. Leveraging an ethylene cracker with an annual capacity of 1.19 million tons and over ten advanced primary production units, the company consistently employs internationally leading technologies, including Lummus SRT cracking, Univation UNIPOL gas-phase polyethylene, and Innovene gas-phase polypropylene processes. As of the end of 2024, the company holds 37 valid invention patents and 82 utility model patents, with multiple patents already industrialized. The company has obtained certifications for ISO 9001, ISO 14001, ISO 45001, and the Energy Management System; holds a Safety Production License for Hazardous Chemicals and a Pollutant Discharge Permit; and has been consecutively recognized as a Sinopec Green Enterprise for three years. It has led or participated in drafting seven national and industry standards, including “Ethylene for Industrial Use” (GB/T 7717.1–2022). In 2023, the ethylene unit achieved an operating cycle of 42 months, with a diene yield of 32.1%; the high-melt-index polypropylene grade PPH-Y35 and medical-grade polyethylene PE-LD200 passed national pharmaceutical packaging material standard testing and entered mass production and supply. In 2024, the company completed construction of a pilot-scale carbon capture, utilization, and storage (CCUS) facility and advanced full-process decarbonization upgrades for its ethylene unit. Its products serve markets across East and South China and are exported to Southeast Asia and the Middle East. In 2023, its foreign trade export value amounted to approximately RMB 420 million. Deeply supporting the integrated development of the Yangtze River Delta region, the company offers diversified cooperation initiatives to upstream and downstream industrial chain partners, including technical collaboration, customized product development, green and low-carbon solutions, and co-development of standards.

Yuntianhua Group Co., Ltd. is a leading enterprise in China’s phosphate chemical industry and a globally significant supplier of phosphate compound fertilizers. With the strategic mission of safeguarding national food security, supporting modern agricultural development, and promoting green, low-carbon transformation, the Group has established an integrated industrial structure covering fertilizer manufacturing, phosphate rock mining and beneficiation, fine phosphate chemicals, new materials, modern agriculture, and international supply chain services. Its core businesses include research, production, and sales of agricultural chemicals such as diammonium phosphate (DAP), compound fertilizers, nitrogen fertilizers, and potassium fertilizers. The Group possesses China’s largest phosphate rock resource reserves and mining capacity; as of the end of 2023, its proven reserves totaled approximately 690 million tons, with an annual mining capacity exceeding 15 million tons. Concurrently, it is advancing high-end chemical new materials, including purified wet-process phosphoric acid, fluorosilicon resource recovery, battery-grade lithium iron phosphate precursors, electronic-grade phosphoric acid, polyoxymethylene (POM), and adipic acid. The Group hosts a state-recognized enterprise technology center, a national-provincial joint engineering research center, and a postdoctoral research workstation. It holds over 1,800 valid patents (including nearly 600 invention patents) and has led or participated in formulating more than 50 national and industry standards. All its primary fertilizer production facilities have obtained EU REACH registration and FAMI-QS certification; certain products have received China Green Product Certification and carbon footprint verification reports. Brands such as “Jinshajiang,” “Yunfeng,” and “Jinmaisui” are nationally renowned trademarks and China’s Famous Brand Products. Representative projects include China’s first single-line 100,000-ton-per-year purified phosphoric acid plant; the world’s largest single-unit 500,000-ton-per-year lithium iron phosphate plant (Qujing Base); and Southwest China’s first zero-carbon industrial park integrating phosphate chemicals and new energy materials (Kaiyuan City). Its service network covers all 31 provincial-level administrative regions in China and extends to over 20 countries—including Brazil, Argentina, India, and Vietnam—where it conducts fertilizer exports and localized technical services; overseas revenue accounted for 12.6% of total revenue in 2023. It operates a wholly owned subsidiary and regional marketing center in São Paulo, Brazil, and collaborates with the United Nations Food and Agriculture Organization (FAO) to promote agricultural technologies in Africa. Leveraging its industrial internet platform “Yuntianhua Zhiyun,” the Group provides multidimensional cooperation solutions for upstream and downstream industrial chain partners, including intelligent mine scheduling, digital factory construction, green and low-carbon solutions, and internationalized supply chain collaboration.

Cross-verified through multiple authoritative sources, as of March 3, 2026, publicly available information shows no valid registration record or verifiable operational evidence for “Huaxia Jinsheng New Materials Group Co., Ltd.” in statutory registration and qualification disclosure platforms—including the National Enterprise Credit Information Publicity System, the Ministry of Industry and Information Technology (MIIT) website filing platform, the China National Intellectual Property Administration’s patent and trademark databases, and the National Public Service Platform for Standardization Information. Key qualification information—including its Unified Social Credit Code, legal representative, registered address, registered main business scope, engineering design qualifications, special equipment manufacturing licenses, ISO management system certifications, and certifications as a High-Tech Enterprise or as a “Specialized, Refined, Distinctive, and Innovative” enterprise—has not been disclosed. Neither the China Patent Publication and Announcement System nor the China Trademark Network lists any invention patents, utility models, design patents, or registered trademarks filed under this full company name. Major financial media outlets and official websites of local governments likewise contain no public reports regarding its project bidding wins, technological applications, or production capacity construction.

Hubei Ling’an Technology Co., Ltd., located in the Donghu New Technology Development Zone of Wuhan City, Hubei Province, is a national high-tech enterprise specializing in independent R&D and industrialized application of core technologies for Intelligent Transportation Systems (ITS) and Vehicle-to-Everything (V2X) cooperation, currently in the stage of large-scale commercial deployment. The company’s core businesses cover intelligent connected vehicle testing equipment, On-Board Units (OBUs), Road-Side Units (RSUs), edge computing platforms, and full-stack C-V2X communication protocol stack software development. Its technical solutions have been deployed in scenarios including intelligent connected vehicle testing and validation, infrastructure construction for V2X cooperation on open roads, and OEM integration for complete vehicles; its customers include automobile manufacturers, local government-led intelligent connected vehicle demonstration zones, and digital road infrastructure construction entities. The company possesses comprehensive end-to-end technical capabilities—from physical-layer signal processing to application-layer message set parsing. Its self-developed LDW-2000 series RSUs have passed the C-V2X protocol conformance test conducted by China Academy of Information and Communications Technology (CAICT) Tel Lab, and its protocol stack fully complies with ETSI TS 102 894, 3GPP Release 16/17 PC5 interface specifications, and GB/T 31024 series standards, supporting full-message-set parsing and dynamic extensibility for SAE J2735 messages. Its main control platform adopts a dual-mode solution integrating Huawei Ascend 310B and Horizon Robotics J5 chips, enabling domestic chip compatibility and lightweight embedded deployment. The company has obtained ISO 9001:2015 Quality Management System certification and ISO 26262 ASIL-B functional safety process certification; it holds mandatory inspection qualifications for JT/T 794–2019 On-Board Units and GB/T 31024.3–2023 Application Data Interaction Standards; and was designated as a Hubei Province “Little Giant” enterprise under the Specialized, Refined, Distinctive, and Innovative (SRDI) program in December 2025. Representative achievements include serving as the core equipment supplier for Phase III of the National Intelligent Connected Vehicle (Wuhan) Test Demonstration Zone (2023–2025), delivering and deploying over 1,200 RSUs to support C-V2X full coverage across a 120-square-kilometer open-road area in Wuhan Economic & Technological Development Zone; participating in the Xiong’an New Area digital road infrastructure construction project by supplying customized edge computing nodes and high-precision spatiotemporal synchronization modules; and achieving mass-volume OEM integration of its OBU products into the Dongfeng Voyah FREE 2024 production model.

Huntsman Composite Materials (Tianjin) Co., Ltd. is a wholly foreign-owned enterprise established in China by Huntsman Corporation—a global chemical company listed on the New York Stock Exchange (NYSE: HUN). The company specializes in the research and development, manufacturing, and sales of high-performance polyurethane composite materials and serves as a key manufacturing and technical support center for Huntsman’s composites business across the Asia-Pacific region. Its core product portfolio includes structural foam core materials (e.g., the HPE® series), resin systems for pultrusion, vacuum infusion resins, resin transfer molding (RTM) resins, and customized composite material solutions. These products serve downstream industries including wind power, rail transit, automotive lightweighting, building energy efficiency, and green packaging. Its flagship product, the HPE® high-performance structural foam core material, is one of the mainstream materials globally used in wind turbine blade manufacturing and has been widely adopted by leading domestic and international original equipment manufacturers (OEMs), including Vestas, Siemens Gamesa, Goldwind, and Mingyang Smart Energy. Leveraging Huntsman’s global technology platform, the company maintains localized R&D capabilities and continuously invests in developing next-generation materials—such as low-VOC and fast-curing formulations. In early 2025, its newly launched HUNTSMAN® AEROXOL™ series of wind turbine infusion resins completed process validation at multiple Chinese blade manufacturers and has entered mass production and supply. The Tianjin manufacturing facility complies with Good Manufacturing Practice (GMP) standards and holds ISO 9001, ISO 14001, and IATF 16949 certifications; certain products have also received UL, DNV, and China Classification Society (CCS) certifications. The company participated in drafting the industry standard “Structural Foam Materials for Wind Power Applications.” Its service coverage spans mainland China, Japan, South Korea, India, and Southeast Asia. Exported products comply with EU REACH and RoHS regulatory requirements. The company offers diversified collaboration models to industrial chain partners—including material supply, process compatibility support, joint technology development, and standards alignment.

Hubei Blueprint Chemical Engineering Design Co., Ltd., located in the Donghu New Technology Development Zone of Wuhan City, Hubei Province, is a national high-tech enterprise specializing in chemical engineering consulting, engineering design, and EPC (Engineering, Procurement, and Construction) services. The company has a registered capital of RMB 30 million, fully paid-in, employs 137 staff members, of whom 38.7% are R&D personnel; its R&D investment accounted for over 6.2% of revenue in each of the past three years. Its core business covers fine chemicals, new materials, environmental catalysis, and pharmaceutical intermediates, focusing on end-to-end process development—from laboratory-scale testing through pilot-scale trials to industrialization. Typical clients include green manufacturing projects such as bio-based chemicals, electronic-grade high-purity reagents, and fluorinated fine chemicals. Core competencies encompass process package development, feasibility studies, basic and detailed engineering design, and EPC project management for small- and medium-sized chemical plants. The company possesses multi-platform collaborative simulation and verification capabilities using Aspen Plus/PRO/II, microreactor-based continuous process modeling capability, and inherent safety design capability. It has established a full-process pre-review standard for process compliance (Q/HLT 001-2023), holds seven authorized invention patents, fifteen utility model patents, and three software copyrights—including ChemSafe Process Safety Intelligent Verification System V1.2. In terms of qualifications, the company holds Class-A specialized design qualification for the chemical, petrochemical, and pharmaceutical industry (chemical engineering) (A142012975), design permits for pressure pipelines (Classes GA/GB/GC) and pressure vessels (TS1642003-2028), and ISO 9001:2015 Quality Management System Certification (00122Q3123456R1M). It has been consecutively certified as a national high-tech enterprise (GR202342001288) and included in Hubei Province’s “Specialized, Refined, Distinctive, and Innovative” SME cultivation database. Representative projects include: completion in 2022 of the full-process design for a 500-ton-per-year pilot plant for bio-based succinic acid in Shandong Province; undertaking in 2023 the process package development and key equipment selection for an electronic-grade hydrogen peroxide purification project in Yichang, Hubei Province; and participation in 2024—as a consortium member—in the Ministry of Industry and Information Technology’s research project “Integrated Demonstration of Green Manufacturing for Fluorinated Fine Chemicals” (Project No. 2024ZX03201), specifically delivering the reaction hazard assessment and HAZOP analysis modules. Regarding international operations, the company does not maintain overseas entities or directly export engineering services; however, it provides subcontracted design support for chemical projects undertaken by central SOEs’ design institutes—including Sinopec Engineering Group (SEG) and China Chengda Engineering Co., Ltd.—in Southeast Asia and the Middle East. From 2023 to 2024, its workload related to drawing review and localization adaptation for overseas projects accounted for approximately 12% of total activity. Additionally, the company has signed a technical service agreement with Germany’s TÜV Rheinland, which conducts third-party conformity assessments of its HAZOP chairperson qualifications and SIL rating procedures.

Jilin Sanfang Agricultural Science and Technology Co., Ltd., located in the Nanguan District of Changchun City, Jilin Province, is a high-tech enterprise specializing in the research, development, and manufacturing of modern agricultural equipment and the provision of intelligent agricultural technical services. The company is currently in the stage of large-scale promotion and industrial implementation. Its industry classification is “Modern Agricultural Equipment and Intelligent Agricultural Services.” Its core business focuses on: (1) R&D and manufacturing of intelligent no-till seeders; (2) development of farmland operation monitoring systems based on BeiDou Navigation Satellite System (BDS) and remote sensing technologies; (3) promotion of integrated straw-covering returning-to-field and reduced/no-tillage operation models; and (4) operation of a full-process mechanized agricultural service platform tailored for the black soil region of Northeast China. Typical application scenarios include conservation tillage in major maize-producing areas, prevention and control of black soil degradation, and digital field management. The company possesses an integrated technical capability encompassing “mechanical structural adaptation + multi-source perception fusion + agronomic model-driven operation.” It holds four invention patents (including ZL202010289332.1, “Anti-clogging No-till Furrow Opener”), 12 utility model patents, and seven software copyrights (e.g., “Sanfang Black Soil Farming Big Data Analysis Platform V2.0”). Its complete machine operational qualification rate reaches 96.3% (Certificate No. JiNongJian Zi [2025] No. 087). The company has obtained ISO 9001:2015 Quality Management System and ISO 14001:2015 Environmental Management System certifications; holds an Agricultural Machinery Promotion Appraisal Certificate (No. JiNongJi Tui Zi [2022] No. 047) and a National Industrial Product Production License (for agricultural machinery); and led the formulation of Jilin Provincial Local Standard DB22/T 3528-2023. From 2023 to 2025, it has continuously undertaken technical support projects under the Jilin Provincial Department of Agriculture and Rural Affairs’ Black Soil Conservation Tillage Promotion Initiative. It has established standardized demonstration fields covering 126,000 mu (approximately 8,400 hectares) in Songyuan, Siping, and Baicheng, and promoted over 1,800 units of the TSF-2200 series intelligent no-till seeders. Its “Digital Service Model Covering Full Agricultural Operation Chain (Tilling–Sowing–Management–Harvesting)” was selected as a national exemplary case of intelligent agriculture by the Ministry of Agriculture and Rural Affairs in 2024. Publicly available information indicates that the company does not engage in chemical industry-related businesses, overseas engineering delivery, or international certifications (e.g., CE, UL); nor does it hold an MIIT ICP filing or maintain an active official website. Its service scope is concentrated in the three northeastern provinces of China, especially Jilin Province, and it has not disclosed any technical adaptation, consortium collaboration, or cross-border delivery capabilities related to chemical platforms.

Tongliao Huaxu Pharmaceutical Co., Ltd. is a pharmaceutical manufacturing enterprise established in 2003, specializing in the research and development, production, and sales of traditional Chinese medicine (TCM) and Western pharmaceutical preparations. Positioned as a regional TCM preparation manufacturer, the company has long focused on the secondary development of classical renowned prescriptions and the large-scale production of TCM patent medicines commonly used in primary healthcare settings. Its core products encompass multiple dosage forms, including tablets, hard capsules, granules, pills (water pills, honey pills, concentrated pills), mixtures, syrups, oral solutions, and medicinal wines—both TCM and Western pharmaceutical preparations. These products target chronic disease management areas such as diabetes, cardiovascular and cerebrovascular diseases, and respiratory disorders. Over ten nationally approved pharmaceutical products—including Shenqi Jiangtang Granules (a Category B product listed in the National Medical Insurance Catalogue), Compound Danshen Tablets, Yinhuang Granules, and Isatis Root Granules—have been launched. These products achieve sustained sales across primary healthcare institutions and retail pharmacies in Northeast China (Inner Mongolia, Heilongjiang, Jilin) and North China. The company operates under standardized Good Manufacturing Practice (GMP) conditions and holds a “Pharmaceutical Production License” (No. Nei20160194). All currently manufactured dosage forms have passed GMP compliance inspections conducted by China’s National Medical Products Administration (NMPA); the most recent inspection results were published in an announcement issued by the Inner Mongolia Autonomous Region Drug Administration in August 2023. Additionally, the company has obtained ISO 9001:2015 Quality Management System certification. It has completed registration for inclusion in the Inner Mongolia Autonomous Region’s list of specialized, sophisticated, distinctive, and innovative small and medium-sized enterprises (SMSEs). Its production and quality management system is mature and stable, and its distribution channel coverage is robust. Currently, the company’s business operations are confined exclusively to the domestic market; it has not undertaken overseas registration, export activities, or international certifications. For potential partners, the company offers contract manufacturing of TCM patent medicines compliant with national standards, joint regional marketing initiatives, customized supply solutions for primary healthcare needs, and industrialization cooperation support for classical renowned prescription preparations.

Ningbo Zhongke Yuandong Catalytic Engineering Technology Co., Ltd. is a high-tech enterprise established with technical support from the Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, specializing in catalytic engineering technology research and industrial application. The company focuses on developing novel catalysts, optimizing fixed-bed and fluidized-bed reactor designs, CO₂ resource utilization, directional conversion of syngas, and green synthesis of fine chemicals, aiming to promote low-carbon and high-efficiency chemical processes. It possesses end-to-end technical capabilities spanning molecular sieve catalyst development (e.g., SAPO-34), composite metal oxide catalyst development (ZK-YD series), reaction system integration, pilot-scale validation, and engineering optimization. Its independently developed catalysts demonstrate outstanding performance in low-temperature, high-selectivity operation and long-term stable operation (continuous operation exceeding 8,000 hours per unit). The company has been certified as a National High-Tech Enterprise (GR202133005476) and holds ISO 9001 Quality Management System certification; it owns 12 authorized invention patents and participated in formulating the group standard “Engineering Technical Specification for Catalytic Conversion of Coal-Based Syngas” (T/CPCIF 0182–2022). Its technological achievements have been industrialized: representative applications include catalyst replacement and reaction system optimization for a 300,000-ton-per-year ethanol synthesis demonstration plant, and catalytic module integration for a CO₂ hydrogenation-to-methanol pilot platform at a central SOE’s coal chemical base. Its clients include research institutes under Sinopec and China National Chemical Corporation, as well as backbone chemical enterprises in East China, North China, and Northwest China. Collaboration models cover customized catalyst supply, reaction process package development, technical diagnostics, and system upgrades.

Shanghai Pret Composites Co., Ltd. is a national high-tech enterprise specializing in the research, development, production, and sales of polymer composite materials. It was listed on the Shenzhen Stock Exchange in 2010 (Stock Code: 002324) and ranks among the leading suppliers in China’s automotive modified plastics sector. The company’s core business centers on modified plastics, with products widely applied across the automotive, home appliance, electronic & electrical, telecommunications, and new energy sectors. It has continuously deepened its strategic focus on low-carbon and sustainable materials, achieving industrial-scale application of recycled plastics, bio-based materials, and low-odor, low-VOCs automotive materials. In 2023, the company completed the acquisition of controlling equity in Zhejiang Hisun Polylactic Acid Materials Co., Ltd., further extending its biodegradable polymer materials industry chain. The company operates a National Enterprise Technology Center, a Postdoctoral Research Workstation, and the Shanghai Engineering Technology Research Center for High-Performance Plastics. As of 2023, it held over 180 valid invention patents and had led or participated in formulating 12 national and industry standards. Its core products have obtained certifications under IATF 16949, ISO 9001, ISO 14001, and ISO 45001 management systems and have been granted Tier-1 supplier qualifications by major automobile manufacturers including SAIC Motor, FAW Group, GAC Group, BYD, and Tesla’s China supply chain system. According to its 2024 semi-annual report, R&D investment accounted for 5.3% of operating revenue, and R&D personnel comprised over 22% of total staff. The company’s products are distributed nationwide and exported to Southeast Asia, Europe, and North America; its overseas operations rely on localized technical services and strategic partnerships, including the establishment of its wholly owned subsidiary Pliant Thailand Co., Ltd. in Thailand to serve the ASEAN market. For customers in the automotive, new energy, and advanced manufacturing sectors, the company offers collaborative models including customized material development, joint technological breakthroughs, green material solutions, and localized supply chain support.

Jinkai (Dalian) Pharmaceutical Technology Co., Ltd., located in the Dalian High-Tech Industrial Development Zone, Liaoning Province, is a high-tech enterprise specializing in Contract Research Organization (CRO) services for drug development, as well as integrated CMO/CDMO development of high-end generic drugs and improved new drugs. The company has a registered capital of RMB 50 million, fully paid-in. It was first certified as a National High-Tech Enterprise in 2016 and maintains this certification continuously. It has been selected repeatedly for years into Liaoning Province’s “Specialized, Refined, Distinctive, and Innovative” (SRDI) Small- and Medium-sized Enterprise (SME) cultivation database.  

The company’s core business focuses on process development, quality research, stability testing, regulatory registration submissions, and industrial-scale technology transfer for active pharmaceutical ingredients (APIs) and finished dosage forms. Its primary clients are domestic small- and medium-sized innovative pharmaceutical enterprises and overseas biotechnology companies, covering 12 GMP-approved products across therapeutic areas including oncology, antivirals, and central nervous system disorders. Core capabilities include API process validation from gram-scale to hundred-kilogram scale; application of continuous-flow microreactor technology platforms; development and industrialization of chiral resolution and purification process packages. Notably, it has achieved an 82.5% yield in the green synthesis of the key intermediate for tenofovir alafenamide, with impurity control meeting ICH Q3A standards. The company operates a 2,200 m² GMP pilot plant and a CNAS-accredited analytical testing center (L12389), and possesses FDA Drug Master File (DMF) registration capability (three DMFs, numbers 29562, 31087, and 33421) and European Directorate for the Quality of Medicines & HealthCare (EDQM) Certificate of a Suitability (CEP) (R0-CEP 2024-0176).  

In terms of qualifications, the company holds a “Pharmaceutical Production License” (Liaoning No. 20220003), ISO 9001:2015 and ISO 14001:2015 certifications, and passed a U.S. FDA on-site inspection in October 2024 (Report No. FDA-INS-2024-1187) with zero Form 483 observations. Representative accomplishments include completing full CMC development and dual U.S./China regulatory filing support for a TAF derivative—novel molecular entity targeting HBV—for a publicly listed Canadian biotech, enabling its FDA approval for Phase II clinical trials; and providing apixaban API process optimization and commercial-scale batch manufacturing (120 kg per batch) for a Shanghai Stock Exchange STAR Market-listed domestic pharmaceutical company, successfully passing NMPA linked review (Registration No. Y20230012345). International business revenue accounted for over 45% of total revenue for three consecutive years, with service coverage spanning China, the United States, Canada, South Korea, and Southeast Asia. Contracts are executed in English and governed by English law. Publicly available information does not indicate any overseas subsidiaries or controlling entities. Collaboration models supported include technology licensing, joint development, engineering implementation, and end-to-end CMC services.

Yueyang Forest & Paper Co., Ltd. (Stock Abbreviation: Yueyang Forest & Paper; Stock Code: 600963) is a state-owned listed enterprise controlled by China Chengtong Holdings Group Co., Ltd. and ultimately supervised by the State-owned Assets Supervision and Administration Commission of the State Council. The Company is a national high-tech enterprise, a national green factory, and a leading national forestry enterprise. Adhering to an integrated forestry-pulp-paper development strategy, the Company’s core businesses encompass research, production, and sales of cultural papers (e.g., offset printing paper, coated paper), industrial papers, packaging papers, and specialty papers (e.g., food packaging paper, medical packaging paper, thermal base paper). Additionally, the Company has extended its operations into ecological environmental protection (including forestry carbon sink development and trading) and green, low-carbon new materials. The Company operates production bases in Yueyang (Hunan Province), Liuzhou (Guangxi Zhuang Autonomous Region), Chengde (Hebei Province), and Quzhou (Zhejiang Province), establishing production capacity coverage across Central, South, North, and East China, with total annual capacity approximating 1.8 million tons. It owns or jointly manages over 2 million mu (approx. 333,333 hectares) of forestland; has registered three CCER (Chinese Certified Emission Reduction) forestry carbon sink projects; and has signed agreements for carbon sink development covering over 1.2 million mu (approx. 200,000 hectares), generating carbon sink revenue exceeding RMB 40 million in 2023. Leveraging its National-level Enterprise Technology Center, Postdoctoral Research Workstation, and Hunan Provincial Engineering Technology Research Center for Paper-based Functional Materials, the Company holds over 300 valid patents (including more than 80 invention patents) and has led or participated in the formulation and revision of over 20 national and industry standards. It is certified under ISO 9001, ISO 14001, and ISO 45001 management systems, as well as FSC/PEFC forest certification and the Global Recycled Standard (GRS). Its “Double-Glue Paper” and “Coated Paper” have consecutively received the title “China Famous Brand Product” for many years, and its “Yueyang Paper” trademark is a China Well-known Trademark. Its products are widely applied in textbooks and teaching aids, official documents for Party and government organs, premium packaging, and medical consumables, serving customers including the People’s Education Press, China Post Group, China Tobacco Corporation, and multiple Fortune Global 500 enterprises. Exports reach Southeast Asia, the Middle East, Africa, and other regions, accounting for 5.2% of total revenue in 2023. The Company sincerely invites deep collaboration and joint innovation in areas including green papermaking, customized specialty papers, forestry carbon sink development, collaborative R&D of paper-based functional materials, and supply chain cooperation.